-
Third-Line Treatment Strategy in mCRC Shifts Focus From Tumor Response to Disease Stabilization
Benjamin A. Weinberg, MD, FACP, discusses the specific therapeutic goals and challenges of third-line metastatic colorectal cancer management.
Category: News
-
Colorectal cancer is rising in younger adults. Here’s who is most at risk and symptoms to watch for
“We’re now starting to see more and more people in the 20-, 30- and 40-year-old range developing colon cancer. At the beginning of my career, nobody that age had colorectal cancer,” said Dr. John Marshall., who has been a cancer doctor for more than three decades. That trend “is shaking us all, to be blunt,” said Marshall.
Category: News
-
Colorectal Cancer Now Leading Cause of Cancer Death in People Younger Than 50 According to New JAMA Report
“I’ve been doing this for 34 years. At the beginning of my career, there were really no patients under the age of 50, apart from an occasional inherited syndrome,” Dr. Marshall said. “I live in a fairly young city, and now approximately half of my patients are under the age of 50” said John Marshall, MD.
Category: News
-
Recognizing How Treatment Differs in Community Setting for CRC
John L. Marshall, MD, discusses the challenges faced by oncologists in managing colorectal cancer treatments seen during a Case-Based Roundtable event.
Category: News
-
MATTERHORN, ATOMIC, CHALLENGE, and More
Dr. Weinberg recaps key gastrointestinal cancer highlights from the 2025 ASCO Annual Meeting.
Category: News
-
Discover how genetic testing can help identify these rare treatment targets
New Lombardi research shows that a safe and effective targeted therapy can slow tumor growth in patients with some types of pancreatic and lung cancers.
Category: News
-
EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer
Dr. Weinberg discusses promising early results from the EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer.
Category: News
-
Excersise and Colorectal Cancer
Dr. Weinberg discussing exercise post-adjuvant chemotherapy for colorectal cancer with Fox5 DC
Category: News
-
Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib:
Dr. Weinberg Discusses Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib
Category: News
-
‘Bad’ Gut Bacteria Tied to Colorectal Cancer in Younger Adults
Dr. Marshall discusses how certain strains of E. coli bacteria during childhood may help explain soaring rates of colorectal cancer
Category: News